Risk factors
Armata Pharmaceuticals (ARMP) risk factors
Item 1A of every Armata Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors35 risks3 new2 dropped9 reworded
Accumulated deficit reached $501.5 million as of December 31, 2025, with ongoing reliance on additional funding.
Filed Mar 25, 2026 - FY2024 10-K risk factors34 risks
Clinical development of novel bacteriophage and synthetic phage technology dominates the risk profile.
Filed Mar 21, 2025